Last reviewed · How we verify

NCT07414862

The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training

Active, enrolled NA Last updated 18 February 2026
What this trial tests

NA trial testing Traditional Hangboard Protocol in Healthy Adult in 36 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
11 November 2025
Primary endpoint
4 April 2026
6 April 2026

Quick facts

Lead sponsorApril Henderson
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment36
Start date11 November 2025
Primary completion4 April 2026
Estimated completion6 April 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

April Henderson

Who can join

18 and older, any sex, with Healthy Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study, is to assess climbing performance metrics that include max strength testing on a rock climbing hangboard, maximum grip strength, assessment of pain and function using the DASH (disability of the arm, shoulder and hand), and maximum flexor strength and maximum extensor strength in climbers who perform a traditional finger training protocol compared to climbers who train both traditional flexor training protocol and extensor tendons.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy Adult

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07414862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing